All results / Stories / Stephanie Henkel

Comic Shop Caters to the New Fandom

Women, cat lovers and new readers gather at Burbank retailer.

Perky Nerd comic book shop targets newbies and women.

Fancy Rehab Helps Dogs After Surgery

K9 Gym caters to pet owners with penchant for trendy treatments.

There’s doggie daycare, dog parks and dog bakeries – so why not doggie rehab? K9 Gym and Rehabilitation Center helps post-surgery pups.

Sweet Spot Attracts the Candy Crowd

Bakers, confectioners gather for second annual Cookie Con.

Burbank couple starts sweet trade show.

Amgen Spinoff

BIOTECH: Atara breaks ground on new Thousand Oaks facility.

Atara Biotherapeutics grows up and into new R&D and manufacturing home in Thousand Oaks.

SEC Investigates ImmunoCellular

The U.S. Securities and Exchange Commission has accused 27 individuals and businesses of stock fraud, according to the Tampa Bay Business Journal, including former ImmunoCellular Therapeutics Ltd. chief executive Manish Singh.

Cunard Debuts Refitted Queen Mary 2

Valencia-based Cunard Line Ltd. has completed a $132 million refit of its flagship ocean liner Queen Mary 2, the company announced Thursday.

Modern Aging

Scott Kaiser, chief innovation officer at the Motion Picture and Television Fund, wants to reinvent geriatric medicine.

Dr. Kaiser, director of innovation at the Motion Picture & Television Fund, wants to improve aging.

Tease photo

Record Payouts Point to Growth for Valley Office

LAW: Lawrance Bohm has won some of the largest employment verdicts ever.

Bohm Law Group has won some of the largest employment judgments in U..S. legal history.

ID Theft Comes to Health Fairs

Chiropractor scammed insurance information, prosecutors allege.

Chiropractor is accused of identity theft at health fairs.

Coach for Counsel

David Ackert borrows from his former acting career when teaching lawyers how to woo potential clients.

David Ackert, president of consulting firm Ackert Inc., switched from TV actor to entrepreneur.

Tease photo

Medical Center Gives Nonprofits Healthy Boost

GRANT: Kaiser Permanente hands out $250,000 to aid 27 organizations in Valley.

Kaiser Permanente Panorama City Medical Center awarded $250,000 in community grant funding to 27 San Fernando Valley nonprofits last month.

IBM’s Watson Matches Wits With Diabetes

Medtronic project pairs company data and supercomputer.

Got diabetes? Now there’s an app for that.

Second Sight Tests Visual Cortex Implant

Second Sight Medical Products Inc. on Tuesday announced the first successful human implantation of a wireless visual cortical stimulator – a big step in the ongoing development of its Orion I Visual Cortical Prosthesis.

Study Brightens Prospects for Second Sight

BIOTECH: Sylmar company’s stock spikes 17 percent on implant announcement.

A UCLA study on visual cortex implant stimulates share prices for Second Sight.

SPECIAL REPORT: Returning Chief

Jennifer Swenson comes back to Simi Valley Hospital to assume the top job with the promise that ‘the best is yet to come.’

Simi Valley Hospital Chief Executive Jennifer Swenson talks about what led her to health care.

Amgen Announces Incubator 'Golden Ticket' Winners

Amgen Inc. announced Thursday its new five-year sponsorship of a San Francisco life sciences incubator called QB3@953, which focuses on developing new human health therapies.

Positive On Progress

INVESTMENT: Guinness Atkinson Funds puts faith in, money on developing world.

Woodland Hills mutual fund has high hopes for global economy.

Tease photo

Mann Down at MannKind

MannKind Corp. announced Friday that Alfred Mann has resigned from his executive chairman and board member positions.

Around the Valleys

News and notes from the greater San Fernando Valley

The Center for Economic Research and Forecasting at California Lutheran University in Thousand Oaks has named Matthew Fienup its new executive director.

Cost-Benefit Quest

New data shows Amgen’s Repatha lowers heart attack risk, but another study found high rejection rates by insurers.

Insurers don’t want to pay for Amgen’s pricey cholesterol drug. Now what?